Category: Pharmaceuticals - Page 2

Economic Impact of Patent Expiration: When Drug Prices Drop 9 Feb 2026
Economic Impact of Patent Expiration: When Drug Prices Drop

When pharmaceutical patents expire, drug prices typically drop by 80% or more-but not always. Learn how generics work, why some drugs stay expensive, and how patients can save thousands.

Antipsychotics and Stroke Risk in Seniors with Dementia: What Doctors Won't Tell You 8 Feb 2026
Antipsychotics and Stroke Risk in Seniors with Dementia: What Doctors Won't Tell You

Antipsychotics are commonly prescribed for dementia-related agitation, but they double stroke risk and increase death rates in seniors. Learn why these drugs are dangerous, what alternatives work better, and how families can protect their loved ones.

Patent Exclusivity vs Market Exclusivity: What's the Real Difference for Drug Companies? 7 Feb 2026
Patent Exclusivity vs Market Exclusivity: What's the Real Difference for Drug Companies?

Patent exclusivity and market exclusivity are two separate legal tools that block generic drugs from entering the market. One comes from the patent office, the other from the FDA - and understanding the difference explains why some drugs stay expensive for years after patents expire.

Tirzepatide for Weight Loss: How Dual Incretin Therapy Works 2 Feb 2026
Tirzepatide for Weight Loss: How Dual Incretin Therapy Works

Tirzepatide (Zepbound) is a dual GLP-1 and GIP agonist that helps people lose up to 22.5% of their body weight. Learn how it works, what to expect, side effects, costs, and how it compares to other weight-loss drugs.

Global Biosimilar Markets: Europe vs United States - How Regulation and Adoption Diverge 26 Jan 2026
Global Biosimilar Markets: Europe vs United States - How Regulation and Adoption Diverge

Europe adopted biosimilars early with clear rules and high adoption. The US lagged due to patents and regulatory hurdles-but is now catching up fast. Here's how the two markets differ and why it matters for patients and costs.

Long-term Safety of Generic vs Brand Drugs: What the Data Really Shows 21 Jan 2026
Long-term Safety of Generic vs Brand Drugs: What the Data Really Shows

Long-term safety studies show generics are generally as safe as brand drugs, but critical exceptions exist - especially for narrow therapeutic index medications. Manufacturer, origin, and individual response matter more than brand vs generic labels.

How to Prevent Early Refills and Duplicate Therapy Mistakes in Pharmacy Practice 19 Jan 2026
How to Prevent Early Refills and Duplicate Therapy Mistakes in Pharmacy Practice

Learn how to stop dangerous early refills and duplicate therapy mistakes in pharmacy practice using proven protocols, EHR tools, and staff training to improve medication safety and prevent overdose risks.

Antiemetics and Cardiac Risks: Understanding QT Prolongation and Drowsiness 17 Jan 2026
Antiemetics and Cardiac Risks: Understanding QT Prolongation and Drowsiness

Not all antiemetics are safe for everyone. Some can dangerously prolong the QT interval or cause severe drowsiness. Learn which drugs carry the highest cardiac risks and how to choose safer alternatives for nausea and vomiting.

Tizanidine and Ciprofloxacin: Why This Drug Combo Can Cause Dangerous Low Blood Pressure and Extreme Drowsiness 14 Jan 2026
Tizanidine and Ciprofloxacin: Why This Drug Combo Can Cause Dangerous Low Blood Pressure and Extreme Drowsiness

Combining tizanidine and ciprofloxacin can cause dangerous drops in blood pressure and extreme drowsiness due to a powerful drug interaction. Learn why this combo is risky and what to do instead.

Bioequivalent medications: what the term really means 11 Jan 2026
Bioequivalent medications: what the term really means

Bioequivalent medications are generic drugs proven to work the same as brand-name versions in the body. Learn how regulators test for equivalence, when it matters, and what you should know before switching.